{"id":"W2012282857","doi":"10.1186/1475-2840-13-102","title":"Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)","year":2014,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Hazard ratio; Placebo; Randomized controlled trial; Internal medicine; Diabetes mellitus; Myocardial infarction; Type 2 diabetes; Clinical trial; Confidence interval; Endocrinology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04795771,0.006374863,0.00625975,0.00187443,0.002553369,0.003471228,0.003566335,0.005818445,0.02875284],"category_scores_gemma":[0.03256366,0.002908036,0.003488553,0.00210961,0.004847077,0.002723647,0.001711926,0.006237282,0.007077775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002317568,"about_ca_system_score_gemma":0.01096859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008453078,"about_ca_topic_score_gemma":0.001518661,"domain_scores_codex":[0.9631069,0.02603523,0.002237875,0.00380296,0.002964503,0.001852425],"domain_scores_gemma":[0.9878043,0.003142304,0.002375097,0.001570658,0.002093479,0.0030141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.8707726,0.01350326,0.007120606,0.01241698,0.003569396,0.0005457546,0.000436091,0.002054949,0.004038311,0.01327649,0.0196447,0.05262093],"study_design_scores_gemma":[0.8787321,0.05018105,0.007178564,0.002247905,0.003938406,0.0002865514,0.0001150455,0.002933016,0.001048623,0.008917847,0.04424334,0.0001776256],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.01474455,0.00363061,0.01035997,0.00295346,0.002507006,0.9562175,0.004593298,0.0001922196,0.004801456],"genre_scores_gemma":[0.02798465,0.0007315747,0.01091502,0.002591227,0.0005456246,0.9548813,0.001035273,0.00001688197,0.00129849],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04795771,"threshold_uncertainty_score":0.2536276,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0208631510821815,"score_gpt":0.2518084300720267,"score_spread":0.2309452789898452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}